Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors

Clinical trial NCT06652529 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06652529
Sponsor: Aromics Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors (Phase 1)Mesothelioma Colorectal Carcinoma Ovarian Cancer NSCLC (Advanced Non-small Cell Lung Cancer)

Start date: 2025-01-01
Primary completion: 2025-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.